Epigenomics AG Forms Medical Advisory Board for Colorectal Cancer Screening
High-profile board to support Epigenomics in development and commercialization of its colorectal cancer screening test in the U.S.
The members of the board include Douglas Rex, MD (Chancellor's Professor and Professor of Medicine at Indiana University School of Medicine), Philip S. Schoenfeld, M.D., M.Ed., M.Sc. (Associate Professor, Department of Internal Medicine, University of Michigan School of Medicine), Deborah Fisher, MD, MHS, (Assistant Professor of Medicine, Duke University), and Scott Ramsey, M.D., Ph.D., (Associate Professor of Medicine and Health Services, Associate Member, Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center).
The four initial members represent a cross section of gastroenterologists with particular expertise in colonoscopy, colorectal cancer screening, evidence-based medicine, outcomes research, and health economic analysis. Epigenomics' Medical Advisory Board will support the company and its corporate partners through design of its prospective clinical validation study and ancillary studies, speaking on behalf of the application of DNA methylation technology to colorectal cancer screening in the U.S., advising on product positioning in the U.S.and support inclusion of blood screening assays into screening guidelines promulgated by US American professional societies.
Most read news
Topics
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.